Yi JM - Search Results

1

Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition.

Yi JM, Zhang XF, Huan XJ, Song SS, Wang W, Tian QT, Sun YM, Chen Y, Ding J, Wang YQ, Yang CH, Miao ZH. Yi JM, et al. Oncotarget. 2015 Apr 20;6(11):8960-73. doi: 10.18632/oncotarget.3264. Oncotarget. 2015. PMID: 25840421 Free PMC article.

2

MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189.

Wang W, Wang YQ, Meng T, Yi JM, Huan XJ, Ma LP, Tong LJ, Chen Y, Ding J, Shen JK, Miao ZH. Wang W, et al. Among authors: yi jm. Mol Cancer Ther. 2014 Jun;13(6):1480-91. doi: 10.1158/1535-7163.MCT-13-0629. Epub 2014 Mar 31. Mol Cancer Ther. 2014. PMID: 24688049

3

Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44.

Yi JM, Huan XJ, Song SS, Zhou H, Wang YQ, Miao ZH. Yi JM, et al. Mol Cancer Ther. 2016 Jul;15(7):1495-503. doi: 10.1158/1535-7163.MCT-15-0753. Epub 2016 Mar 29. Mol Cancer Ther. 2016. PMID: 27197304

4

LSD1 inhibition attenuates targeted therapy-induced lineage plasticity in BRAF ^V600E colorectal cancer.

Ladaika CA, Chakraborty A, Masood A, Hostetter G, Yi JM, O'Hagan HM. Ladaika CA, et al. Among authors: yi jm. bioRxiv [Preprint]. 2024 Oct 29:2024.10.25.620306. doi: 10.1101/2024.10.25.620306. bioRxiv. 2024. PMID: 39554172 Free PMC article. Preprint.

5

Bojungikki-Tang Augments Pembrolizumab Efficacy in Human PBMC-Injected H460 Tumor-Bearing Mice.

Na SW, Yi JM, Yeo H, Park SM, Jeong M, Chun J, Jeong MK. Na SW, et al. Among authors: yi jm. Life (Basel). 2024 Sep 30;14(10):1246. doi: 10.3390/life14101246. Life (Basel). 2024. PMID: 39459546 Free PMC article.

6

Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR.

Kang JH, Uddin N, Kim S, Zhao Y, Yoo KC, Kim MJ, Hong SA, Bae S, Lee JY, Shin I, Jin YW, O'Hagan HM, Yi JM, Lee SJ. Kang JH, et al. Among authors: yi jm. Mol Cancer. 2024 Oct 16;23(1):230. doi: 10.1186/s12943-024-02150-4. Mol Cancer. 2024. PMID: 39415210 Free PMC article.

7

Discovery and Prediction Study of the Dominant Pharmacological Action Organ of Aconitum carmichaeli Debeaux Using Multiple Bioinformatic Analyses.

Park M, Seo EH, Yi JM, Cha S. Park M, et al. Among authors: yi jm. Int J Mol Sci. 2024 Sep 23;25(18):10219. doi: 10.3390/ijms251810219. Int J Mol Sci. 2024. PMID: 39337710 Free PMC article.

8

KORE-Map 1.0: Korean medicine Omics Resource Extension Map on transcriptome data of tonifying herbal medicine.

Park M, Park SM, Lee H, Kim A, Kim NS, Kim YR, Yi JM, Cha S. Park M, et al. Among authors: yi jm. Sci Data. 2024 Sep 6;11(1):974. doi: 10.1038/s41597-024-03734-x. Sci Data. 2024. PMID: 39242618 Free PMC article.

9

Epigenetic regulation of HERVs: Implications for cancer immunotherapy.

Yi JM. Yi JM. Genes Genomics. 2024 Nov;46(11):1303-1312. doi: 10.1007/s13258-024-01546-2. Epub 2024 Aug 1. Genes Genomics. 2024. PMID: 39088189 Review.

10

Inhibitory Action of 1,3,5-Trihydroxybenzene on UVB-Induced NADPH Oxidase 4 through AMPK and JNK Signaling Pathways.

Lim C, Piao MJ, Kang KA, Fernando PDSM, Herath HMUL, Kim DW, Yi JM, Choi YH, Hyun JW. Lim C, et al. Among authors: yi jm. Biomol Ther (Seoul). 2024 Jul 1;32(4):499-507. doi: 10.4062/biomolther.2024.054. Epub 2024 Jun 25. Biomol Ther (Seoul). 2024. PMID: 38914480 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters